Clinical Trials in Norway / NCT04942041
Recruiting Observational

Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality

NCT04942041 · tracked via the Priya Life Science Norway tracker
Phase
Observational
Started
2021-01-01
Last updated
2023-12-29

Condition(s) studied

Stroke, Acute Ischemic

Investigational drug(s) / intervention(s)

Simulation based quality program

Simulation based quality program: Stroke team simulation. Virtual reality task training simulation.

Study summary

The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients * Large vessel occlusion stroke Exclusion Criteria: * Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area * More than 24 hours after stroke onset

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sørlandet Hospital Health Trust Kristiansand Agder Recruiting

More Sorlandet Hospital HF trials in Norway

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04942041 on ClinicalTrials.gov ↗ ← All trials in Norway